Skip to main content

LIVE

IRMD

IRadimed Corporation

IRMD

NASDAQ·Healthcare·Medical - Devices·Mkt cap $1.1B

$83.45

-3.63%

P/E

46.62

Mkt Cap

$1.1B

52-Wk Range

$67.84–$107.90

52-Week Range

$67.84 - $107.90

P/E

46.62

Fwd P/E

39.93

Beta

0.90

Div Yield

1.52%

Avg Vol

132.6K

Shares Out

12.8M

Mkt Cap

$1.1B

Price action

Price chart

Up 16.1% over the trailing year

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

4 reasons

  • Proprietary MRI-compatible technology with limited direct competition in specialized market
  • Established relationships with hospitals and imaging centers requiring regulatory compliance solutions
  • Recurring revenue model through disposable IV tubing sets and accessories
  • Regulatory certifications and clearances creating barriers to entry for competitors

Bear Case

2 risks

  • Average volatility.
  • Significant premium - growth priced in

Growth

Stable outlook

Increasing global MRI procedure volumes and hospital adoption rates

Value

Significant premium - growth priced in

Momentum

Weak

-11.6% over 3m

Quality

Excellent

Strong fundamentals

Dividend

Modest

1.52% yield

Earnings track record

Latest print - beat on both lines

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Nov 2, 2026

Q3 26 RECAP

JUL 31, 2026

Reported EPS of $0.46 vs $0.44 consensus (+4.5% surprise). Revenue of $20.5M vs $20.4M expected (+0.6%). Beat on both top and bottom lines.

EPS beat +4.5%
Rev beat +0.6%
Double beat

EPS surprise · last 4Q

1 of 1 beats

Estimate

Actual

Q3 26

+4.5%

Revenue trend · last 8Q

+11%

+11%

+14%

+16%

+17%

+13%

+0%

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

Q2 26

$18.3M

$19.4M

$19.5M

$20.4M

$21.2M

$22.7M

$22.0M

$20.5M

Margins · last 8Q

Gross

74.1%

Operating

31.2%

Profit

25.5%

Wall Street consensus

Analyst coverage

Live ratings and price targets aggregated across covering analysts.

vs Industry

How IRMD stacks vs Medical - Devices

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.